GlaxoSmithKline

New Business

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…

Read More »
New Business

GSK signs US$12.5 billion licence deal with Hengrui as China rises in global pharmaceuticals

GlaxoSmithKline (GSK) will pay a Chinese company US$12.5 billion for exclusive global rights to develop a dozen drugs, in a…

Read More »
Back to top button